Credit Suisse’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $556K | Hold |
|
|||||
|
2023
Q4 | $548K | Buy |
|
|||||
|
2023
Q3 | $439K | Sell |
|
|||||
|
2023
Q2 | $460K | Sell |
|
|||||
|
2023
Q1 | $374K | Sell |
|
|||||
|
2022
Q4 | $447K | Buy |
|
|||||
|
2022
Q3 | $440K | Buy |
|
|||||
|
2022
Q2 | $501K | Sell |
|
|||||
|
2022
Q1 | $639K | Buy |
|
|||||
|
2021
Q4 | $709K | Sell |
|
|||||
|
2021
Q3 | $954K | Buy |
|
|||||
|
2021
Q2 | $1.08M | Sell |
|
|||||
|
2021
Q1 | $1.4M | Buy |
|
|||||
|
2020
Q4 | $1.37M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $296K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $203K | Buy |
|
|||||
|
2019
Q1 | $211K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $388K | Sell |
|
|||||
|
2018
Q2 | $721K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $1.02M | Sell |
|
|||||
|
2017
Q3 | $1.77M | Buy |
|
|||||
|
2017
Q2 | $1.67M | Sell |
|
|||||
|
2017
Q1 | $2.16M | Buy |
|
|||||
|
2016
Q4 | $1.91M | Sell |
|
|||||
|
2016
Q3 | $3.57M | Buy |
|
|||||
|
2016
Q2 | $2.42M | Buy |
|
|||||
|
2016
Q1 | $2.18M | Sell |
|
|||||
|
2015
Q4 | $2.68M | Buy |
|
|||||
|
2015
Q3 | $1.22M | Sell |
|
|||||
|
2015
Q2 | $2.7M | Sell |
|
|||||
|
2015
Q1 | $7.06M | Buy |
|
|||||
|
2014
Q4 | $4.74M | Sell |
|
|||||
|
2014
Q3 | $7.36M | Buy |
|
|||||
|
2014
Q2 | $761K | Buy |
|
|||||
|
2014
Q1 | $545K | Sell |
|
|||||
|
2013
Q4 | $702K | Buy |
|
|||||
|
2013
Q3 | $426K | Buy |
|